Preclinical studies demonstrate that DSIP can alter pain threshold responses, with observed effects that are not reversed by opioid receptor antagonists such as naloxone, suggesting involvement of non-opioid or indirect neuromodulatory pathways [7]
Martin LJ (2002) Peptides, hormones, and the brain and spinal cord
Microdosing GLP-1 or GLP-1/GIP refers to using lower doses of the medication to support long-term health and longevity, rather than for diabetes or weight management
Look for ingredients like hyaluronic acid, vitamin C, peptides, and zinc
When Results Plateau In community-reported reta+cagri protocols, plateaus are commonly reported at: Month 68 for users who hold retatrutide at 2 mg/week typically resolves by titrating retatrutide to 3 mg or holding while cagrilintide finishes ramping to 2.4 mg Month 12+ for users at the community ceiling (reta 4 mg + cagri 2.4 mg) no additional dose lever within the conservative community protocol